CRISPR Therapeutics

The 2023 Good Tech Awards

Toasting a year of breakthroughs (and a few breakdowns) in Silicon Valley and beyond.

F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing

People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.

Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval

The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.

Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients

The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.

Sickle Cell Cure Brings Mix of Anxiety and Hope

Some people who have long lived with the disease say they worry about living as a healthy person, while others worry about the obstacles to getting treatment.